Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 21
2016 1
2018 5
2019 6
2020 5
2021 14
2022 1
2023 6
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 34292696

41 results

Results by year

Filters applied: . Clear all
Page 1
Eptinezumab.
[No authors listed] [No authors listed] 2021 Jul 9. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2021 Jul 9. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 34292696 Free Books & Documents. Review.
Eptinezumab: First Approval.
Dhillon S. Dhillon S. Drugs. 2020 May;80(7):733-739. doi: 10.1007/s40265-020-01300-4. Drugs. 2020. PMID: 32266704 Review.
Eptinezumab for the preventive treatment of migraine.
Villar-Martínez MD, Moreno-Ajona D, Goadsby PJ. Villar-Martínez MD, et al. Pain Manag. 2021 Mar;11(2):113-121. doi: 10.2217/pmt-2020-0075. Epub 2020 Dec 7. Pain Manag. 2021. PMID: 33280422 Review.
Eptinezumab for the treatment of migraine.
Scuteri D, Corasaniti MT, Tonin P, Bagetta G. Scuteri D, et al. Drugs Today (Barc). 2019 Nov;55(11):695-703. doi: 10.1358/dot.2019.55.11.3069864. Drugs Today (Barc). 2019. PMID: 31840684 Review.
Eptinezumab for the treatment of migraine.
Spuntarelli V, Negro A, Luciani M, Bentivegna E, Martelletti P. Spuntarelli V, et al. Expert Opin Biol Ther. 2021 Aug;21(8):999-1011. doi: 10.1080/14712598.2021.1931678. Epub 2021 Jun 1. Expert Opin Biol Ther. 2021. PMID: 34009094 Review.
Rimegepant.
[No authors listed] [No authors listed] 2025 Jan 12. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2025 Jan 12. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 34324285 Free Books & Documents. Review.
Ubrogepant.
[No authors listed] [No authors listed] 2025 Jan 12. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2025 Jan 12. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 34324284 Free Books & Documents. Review.
A Review of Eptinezumab Use in Migraine.
Datta A, Maryala S, John R. Datta A, et al. Cureus. 2021 Sep 16;13(9):e18032. doi: 10.7759/cureus.18032. eCollection 2021 Sep. Cureus. 2021. PMID: 34540516 Free PMC article. Review.
41 results